EUROFINS SCIENT (ERFSF)
(Delayed Data from OTC)
$73.90 USD
+1.40 (1.94%)
Updated Sep 19, 2025 03:51 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, EUROFINS SCIENT has a market cap of $13.99B, which represents its share price of $72.49 multiplied by its outstanding shares number of 192.98M. As a large-cap company, ERFSF's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
ERFSF 73.90 +1.40(1.94%)
Will ERFSF be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ERFSF based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ERFSF
EUROFINS SCIENT (ERFSF) Upgraded to Buy: What Does It Mean for the Stock?
Has BioNTech (BNTX) Outpaced Other Medical Stocks This Year?
ERFSF: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is Encompass Health (EHC) Stock Outpacing Its Medical Peers This Year?
EUROFINS SCIENT (ERFSF) Upgraded to Strong Buy: Here's Why
Is EUROFINS SCIENT (ERFSF) Outperforming Other Medical Stocks This Year?
Other News for ERFSF
Eurofins Scientific price target raised by EUR 2 at Morgan Stanley
Tracking Ruane, Cunniff, & Goldfarb's Portfolio - Q2 2025 Update
What Worked In Q2: Longleaf's Most Impactful Global Holdings
Eurofins Scientific price target raised by EUR 8 at Berenberg
Eurofins Scientific price target raised by EUR 10.40 at Citi